InsiderClue
← All stocks

MEDIFAST INC

MED Net buying
CIK 0000910329 #4193 in the set updated 17 Sep 2026
Bought (1 mo)
$1.42M
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$1.42M
+$1.42M against sales at will

By person

10 insiders · 8 transactions
2.5×

Daniel R. Chard holds only 2.5 times base salary in stock. $2.53M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel R. Chard last reported holding, valued at $12.26, the price Common Stock was last bought or sold at on the open market here, on 26 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kiai Parsa
Director
$1.42M (8)
—
+$1.42M
58,682
0.5249%
$719.63K
—
Chard Daniel R
Chairman & CEO
—
—
—
205,911
1.84%
$2.53M
+250.7%
Maloney James P.
Chief Financial Officer
—
—
—
73,033
0.6532%
$895.62K
+273.9%
SCHLACKMAN SCOTT
Director
—
—
—
42,229
0.3777%
$517.86K
+193.6%
BROWN JEFFREY J
Director
—
—
—
38,578
0.3450%
$473.09K
+114.8%
Thomas Andrea B
Director
—
—
—
35,697
0.3193%
$437.76K
+177.8%
Geary Elizabeth A.
Director
—
—
—
31,225
0.2793%
$382.92K
+272.7%
Hoer Michael A.
Director
—
—
—
26,139
0.2338%
$320.55K
+74.6%
MacKenzie Jonathan Barrett
VP, Finance & CAO
—
—
—
20,838
0.1864%
$255.54K
+433.5%
Rose Jeffrey Matthew
Director
—
—
—
18,419
0.1647%
$225.88K
—

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Kiai Parsa
26 Aug 2026
Director
Buy indirect
1,175
$12.26
$14.41K
Kiai Parsa
26 Aug 2026
Director
Buy indirect
41,975
$12.26
$514.75K
Kiai Parsa
24 Aug 2026
Director
Buy indirect
118
$12.00
$1.42K
Kiai Parsa
24 Aug 2026
Director
Buy indirect
4,211
$12.00
$50.53K
Kiai Parsa
20 Aug 2026
Director
Buy indirect
1,175
$11.60
$13.63K
Kiai Parsa
20 Aug 2026
Director
Buy indirect
41,975
$11.60
$487.07K
Kiai Parsa
19 Aug 2026
Director
Buy indirect
799
$11.66
$9.31K
Kiai Parsa
19 Aug 2026
Director
Buy indirect
28,538
$11.66
$332.68K

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 4 Oct 2016